Overview

Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio in Healthy Subjects

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
A bioequivalence study of lithium carbonate will be developed in 24 healthy subjects, in fasting condition
Phase:
PHASE4
Details
Lead Sponsor:
Centro de Atencion e Investigacion Medica
Treatments:
Lithium Carbonate